ArticleArthritis research & therapy2020

Interleukin-18 and fibroblast growth factor 2 in combination is a useful diagnostic biomarker to distinguish adult-onset Still's disease from sepsis.

Tomohiro Koga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.